Our Investor Hub

Stock Information

CEO Thomas Lingelbach comments on Valneva‘s Full Year 2025 Results

Upcoming Events

November 16, 2026

Jefferies Global Healthcare Conference

H1 2026 Financial Results

View the H1 2026 Financial Results webcast
here.

View the Analyst Presentation for H1 2026 Financial Results
here.

Quick Links

Check out our 2025 Annual Business Report

View More

Contact

Investor Relations Team

Îlot Saint-Joseph,
Bureaux Convergence, Bât. A,
12 ter Quai Perrache,
69002 Lyon, France

T: +33 4 78 76 61 01 investors@valneva.com

Subscribe to Valneva News

Submit

Press Releases

August 14, 2026

Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

August 13, 2026

Valneva Reports Half Year 2026 Financial Results and Provides Corporate Updates

July 22, 2026

Valneva to Report First Half 2026 Consolidated Financial Results on August 13, 2026

View More